10 Best 52-Week Low Penny Stocks to Buy Now
On March 26, Gabelli released its Small Cap Outlook for 2025 and beyond.
Maxcyte Inc. (MXCT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cadian Capital Eric Bannasch | 10,027,727 | $27,375,695 | +8% | 1.17% |
| 2. | Millennium Management Israel Englander | 1,378,329 | $3,762,838 | -50% | 0% |
| 3. | Royce & Associates Chuck Royce | 1,040,873 | $2,841,583 | +31% | 0.03% |
| 4. | Renaissance Technologies Jim Simons | 367,900 | $1,004,367 | +31% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 237,642 | $648,763 | -38% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.90 | 70,443 | $345,241.14 | 100,000 | 2024-06-10 | Filing | |
| $4.87 | 29,557 | $143,824.36 | 29,557 | 2024-06-07 | Filing | |
| $4.32 | 80,000 | $345,480.00 | 100,000 | 2023-03-29 | Filing | |
| $11.12 | 20,000 | $222,400.00 | 20,000 | 2021-11-22 | Filing | |
| $13.00 | 1,800,000 | $23,400,000.00 | 13,971,334 | 2021-07-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.18 | 1,211 | $3,850.13 | 59,439 | 2025-03-18 | Filing | |
| $3.18 | 353 | $1,122.29 | 64,219 | 2025-03-18 | Filing | |
| $3.18 | 6,939 | $22,061.16 | 111,811 | 2025-03-18 | Filing | |
| $4.65 | 3,000 | $13,935.00 | 141,950 | 2025-01-27 | Filing | |
| $4.54 | 4,466 | $20,271.62 | 41,447 | 2025-01-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,480,488 | $5,408,636 | 0% | |
| 2. | 1,723,239 | $3,756,661 | 0.01% | |
| 3. | 345,815 | $753,876 | 0% | |
| 4. | 248,002 | $540,644 | 0% | |
| 5. | 237,245 | $493,469 | 0% |
News See All
MaxCyte, Inc. (NASDAQ:MXCT) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the MaxCyte Second Quarter Earnings Conference Call. [Operator Instructions] Today's conference is being recorded.
MaxCyte, Inc. (MXCT): A Bull Case Theory
We came across a bullish thesis on MaxCyte, Inc. (MXCT) on Substack by OppCost. In this article, we will summarize the bulls’ thesis on MXCT. MaxCyte, Inc.
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the MaxCyte First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by and welcome to MaxCyte's Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q3 2024 Earnings Call Transcript
Operator: Hello and welcome to MaxCyte Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to MaxCyte Second Quarter Earnings Conference Call.
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the MaxCyte First Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript
MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.1. MaxCyte, Inc.
Hedge Funds Say These Penny Stocks Are Poised to Explode
Despite common belief, not all penny stocks are inherently risky and suitable only for short-term gains.
Billionaire Hedge Funds
